AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 6 1145-R1151, Copyright © 1991 by American Physiological Society

ARTICLES

Interactions between ANP and ANG II in regulating blood pressure and sympathetic outflow

M. K. Steele, D. G. Gardner, P. L. Xie and H. D. Schultz
Department of Physiology, University of California, San Francisco 94143-0444.

In anesthetized rats with sinoaortic denervation, intracerebroventricular (icv) injection of atrial natriuretic peptide (ANP) resulted in decreased mean arterial blood pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) (depressor effects), whereas icv angiotensin II (ANG II) produced increases in these variables (pressor effects). The depressor effects of ANP were slower in onset and longer in duration than the pressor effects of ANG II. Intracerebroventricular injection of the ANG II-receptor blocker sarthran or the ANG II-synthesis inhibitor captopril resulted in a significant reduction in MAP; HR and RSNA were not affected. Both sarthran and captopril abolished the depressor responses to icv ANP. In contrast, injection of an anti-rat ANP antibody, which blocked the depressor effects of icv ANP, did not by itself modify MAP, HR, or RSNA, nor did the antibody affect the pressor responses to icv ANG II. These data suggest that, in this animal model, the depressor effects of icv ANP are mediated by the inhibition of brain ANG II-dependent neural activity. These results also demonstrate that, in this preparation, the endogenous ANG II system actively contributes to the maintenance of basal MAP, whereas the central ANP system, at least in regions accessible to the antirat ANP antibody, plays little role in this maintenance.

This article has been cited by other articles:

				S.-G. Wei and R. B. Felder Forebrain renin-angiotensin system has a tonic excitatory influence on renal sympathetic nerve activity Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H890 - H895. [Abstract] [Full Text] [PDF]

				E. Berendes, H. Van Aken, C. Raufhake, C. Schmidt, G. Assmann, and M. Walter Differential Secretion of Atrial and Brain Natriuretic Peptide in Critically Ill Patients Anesth. Analg., September 1, 2001; 93(3): 676 - 682. [Abstract] [Full Text] [PDF]

				L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF]

				U. Ackermann and N. Azizi Increased central AT1-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1441 - R1445. [Abstract] [Full Text] [PDF]

				B. F. Palmer Hyponatraemia in a neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting Nephrol. Dial. Transplant., February 1, 2000; 15(2): 262 - 268. [Full Text] [PDF]

				L. G. Melo, A. T. Veress, C. K. Chong, U. Ackermann, and H. Sonnenberg Salt-sensitive hypertension in ANP knockout mice is prevented by AT1 receptor antagonist losartan Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R624 - R630. [Abstract] [Full Text] [PDF]

				E. R. Levin, D. G. Gardner, and W. K. Samson Natriuretic Peptides N. Engl. J. Med., July 30, 1998; 339(5): 321 - 328. [Full Text] [PDF]